跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JAMP-DORZOLAMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
JAMP-DORZOLAMIDE
Authorized
STANDARD
JAMP-DORZOLAMIDE
Jamp Pharma Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1cbc9b18c49539b3
Company
Jamp Pharma Corporation
Type
Standard
Approval Details
Approval Id
1cbc9b18c49539b3
Drug Approval Canada Name
JAMP-DORZOLAMIDE
Product Name
JAMP-DORZOLAMIDE
Status
Marketed
Status Date
2019-12-24
Original Market Date
2019-12-24
Din
02453347
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.12
Atc Original
S01EC03 DORZOLAMIDE
Atc Name
s 01 ec 03
Aig Number
0128558001
Company Name
Jamp Pharma Corporation
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Company Detail Path
/organization/jamp-pharma-corporation
Company Information
Pharmaceutical Company Name
Jamp Pharma Corporation
Country Name
Canada
Province Name
British Columbia
City Name
chilliwack,british columbia,country_ca
Address
8065 Aitken Rd
Active Ingredients
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
2 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1cbc9b18c49539b3
Type
Standard
Back to Health Canada Approvals